Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:GRDN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGRDNGuardian Pharmacy Services$40.81+4.3%$37.51$19.17▼$41.36$2.03B0.08385,732 shs494,853 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGRDNGuardian Pharmacy Services+0.83%+0.57%+5.02%+15.80%+80.58%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGRDNGuardian Pharmacy Services$40.81+4.3%$37.51$19.17▼$41.36$2.03B0.08385,732 shs494,853 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGRDNGuardian Pharmacy Services+0.83%+0.57%+5.02%+15.80%+80.58%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGRDNGuardian Pharmacy Services 2.78Moderate Buy$41.331.29% UpsideCurrent Analyst Ratings BreakdownLatest GRDN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/11/2026GRDNGuardian Pharmacy Services Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C)5/11/2026GRDNGuardian Pharmacy Services Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/7/2026GRDNGuardian Pharmacy Services OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$38.00 ➝ $43.004/27/2026GRDNGuardian Pharmacy Services Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$42.004/13/2026GRDNGuardian Pharmacy Services Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$38.00 ➝ $43.003/30/2026GRDNGuardian Pharmacy Services Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$44.003/27/2026GRDNGuardian Pharmacy Services Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)3/18/2026GRDNGuardian Pharmacy Services Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy3/12/2026GRDNGuardian Pharmacy Services Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$40.003/12/2026GRDNGuardian Pharmacy Services Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$34.00 ➝ $38.00(Data available from 6/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGRDNGuardian Pharmacy Services$1.45B1.40$1.32 per share30.90$3.44 per share11.86Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGRDNGuardian Pharmacy Services$49.22M$0.8349.1631.152.553.64%30.72%15.99%8/10/2026 (Estimated)Latest GRDN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2026Q1 2026GRDNGuardian Pharmacy Services$0.24$0.29+$0.05$0.21$329.89 million$336.60 million3/11/2026Q4 2025GRDNGuardian Pharmacy Services$0.27$0.37+$0.10$0.33$390.04 million$397.62 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthGRDNGuardian Pharmacy ServicesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGRDNGuardian Pharmacy ServicesN/A1.461.17Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGRDNGuardian Pharmacy ServicesN/AInsider OwnershipCompanyInsider OwnershipGRDNGuardian Pharmacy Services32.96%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGRDNGuardian Pharmacy Services3,60049.78 million33.37 millionN/AGRDN HeadlinesRecent News About These CompaniesRoyce & Associates LP Reduces Stake in Guardian Pharmacy Services, Inc. $GRDNMay 30, 2026 | marketbeat.comGuardian Pharmacy Extends Revolving Credit Facility and FlexibilityMay 28, 2026 | tipranks.comGuardian Pharmacy Services, Inc. (NYSE:GRDN) Receives $41.33 Average Price Target from BrokeragesMay 24, 2026 | americanbankingnews.comTimesSquare Capital Management LLC Has $31.54 Million Position in Guardian Pharmacy Services, Inc. $GRDNMay 19, 2026 | marketbeat.comGuardian Pharmacy Services, Inc. (NYSE:GRDN) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMay 19, 2026 | marketbeat.comStatutory Profit Doesn't Reflect How Good Guardian Pharmacy Services' (NYSE:GRDN) Earnings AreMay 14, 2026 | finance.yahoo.comGuardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 13, 2026 | seekingalpha.comGuardian Pharmacy Services Signals Strength Amid IRA ShockMay 10, 2026 | tipranks.comGuardian Pharmacy Services Q1 Earnings Call HighlightsMay 10, 2026 | marketbeat.comThe Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Strong Q1 Beat And New Shelf RegistrationMay 10, 2026 | finance.yahoo.comGuardian Pharmacy Services (NYSE:GRDN) Stock Rating Lowered by Wall Street ZenMay 9, 2026 | marketbeat.comGuardian Pharmacy Services (NYSE:GRDN) Issues Quarterly Earnings ResultsMay 8, 2026 | marketbeat.comGuardian Pharmacy Services, Inc. Class A (GRDN) Receives a Buy from Bank of America SecuritiesMay 8, 2026 | theglobeandmail.comGuardian Pharmacy Services, Inc. (NYSE:GRDN) Q1 2026 Earnings Call TranscriptMay 8, 2026 | insidermonkey.comGuardian Pharmacy Stockholders Back Directors, Pay and AuditorMay 7, 2026 | tipranks.comGuardian Pharmacy Services forecasts $123M-$127M adjusted EBITDA amid ira pricing resetMay 7, 2026 | seekingalpha.comGuardian Pharmacy Services (NYSE:GRDN) Price Target Raised to $43.00 at OppenheimerMay 7, 2026 | marketbeat.comGuardian Pharmacy Services (GRDN) Q1 Earnings and Revenues Surpass EstimatesMay 6, 2026 | zacks.comGuardian (GRDN) Q1 2026 Earnings TranscriptMay 6, 2026 | finance.yahoo.comGuardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call TranscriptMay 6, 2026 | seekingalpha.comGuardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year GuidanceMay 6, 2026 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGRDN Company DescriptionsGuardian Pharmacy Services NYSE:GRDN$40.80 +1.67 (+4.25%) Closing price 03:59 PM EasternExtended Trading$40.90 +0.10 (+0.24%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand Medtronic Bottoms, Healthy Rebound Ahead From Runway to Riches: Victoria's Secret's New Look Coke's $10B India IPO Plan Pops the Top on Hidden Value Dell's AI Toll Bridge Is Paved with Record Margins The Blue Origin Explosion Is a Setback for Amazon, Not a Dealbreaker GitLab’s Price Recovery Gains Traction—Time to Get On Board? Ulta's Q1 Report Primes It for a Beauty of a Rebound Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
